Crispr / Cas9 system
Prepared by
Ammar H. Abbas
Supervised by
Dr. Raya ALSaade
Introduction
CRISPR- Cas9 : is clustered, regularly interspaced, short
palindromic repeat and the associated Cas9 protein is
naturally an adaptive immunity mechanism in
prokaryotes.
CRISPRs are found in approximately 40% of sequenced
bacterial genomes and 90% of sequenced archaea.
Clustered Regularly Interspaced Short Palindromic Repeats
Repeat Spacer Spacer Spacer
Bacteriophage
Cas 9 is an endonuclease, first identified from Streptococcus
pyogenes bacteria. It’s genes are often located next to
CRISPR repeat-spacer arrays.
Specificity of CRISPR-Cas9 depends on the presence of a
sequence-specific Protospacer Adjacent Motif (PAM) and
target sequence (20 bases).
Absence of PAM in host genome enable to avoid self-
cleavage.
• CRISPR-Cas9 was adapted from a naturally occurring genome editing
system that bacteria use as an immune defense.
• When infected with viruses, bacteria capture small pieces of the viruses'
DNA and insert them into their own DNA in a particular pattern to create
segments known as CRISPR arrays.
• The CRISPR arrays allow the bacteria to "remember" the viruses (or
closely related ones). If the viruses attack again, the bacteria produce
RNA segments from the CRISPR arrays that recognize and attach to
specific regions of the viruses' DNA.
• The bacteria then use Cas9 or a similar enzyme to cut the DNA apart,
which disables the virus.
The Principle
Three Stages of CRISPR-Cas9
Stage I: Acquisition- DNA fragments of invading phages are incorporated into the host
CRISPR locus as spacers between repeats.
Stage II: Expression/Biogenesis- Cas proteins are expressed, the CRISPR array
containing acquired spacers is transcribed into pre-crRNA, and then cleaved into
mature crRNAs.
Stage III: Cleavage/Interference- Cas proteins recognize the appropriate target with
the guidance of the crRNA and mediate the cleavage of the invading genome to
generate double strand brakes (DSB) at 3 bp upstream of PAM sequence.
1
2
Phage Phage
Phage genes
CRISPR RNAs
Phage genes
Transcription
Repeat Repeat Repeat Repeat Repeat Repeat Repeat Repeat Repeat Repeat Repeat Repeat
CRISPR region CRISPR region
Components of
Crispr system
Double Strand Break is
generated, then
What???
Nonhomologous DNA end joining (NHEJ) homology-directed repair
insertions/deletions (indels) single-stranded oligodeoxynucleotide (ssODN)
CRISPR-Cas9 – a highly specific genome editor
Knock genes out – disable them
Precisely replace genes or insert
new ones
Increase or decrease expression of
genes
Faster, cheaper, more accurate, more efficient.
Genome editing
• In 2012, researchers demonstrated that RNAs could be
constructed to guide a Cas nuclease (Cas9 was the first
used) to any DNA sequence. The so-called guide RNA can
also be made so that it will be specific to only that one
sequence, improving the chances that the DNA will be cut
at that site and nowhere else in the genome. Further testing
revealed that the system works quite well in all types of
cells, including human cells.
CRISPR/Cas9 Current and Prospective Application
Gene Therapy and
Other Therapeutic
Gene Function Study Agriculture
GMO food
Current and
Disease Vector Control Biofuel Industry
Prospective
Application
Enhancement Gene
Organ Transplantation Edition
Animal Disease
Model
12
Limitations
CRISPR/Cas is an extremely powerful tool, but it has important
limitations. It is:
• difficult to deliver the CRISPR/Cas material to mature cells in
large numbers, which remains a problem for many clinical
applications. Viral vectors are the most common delivery
method.
• not 100% efficient, so even the cells that take in CRISPR/Cas
may not have genome editing activity.
• not 100% accurate, and “off-target” edits, while rare, may
have severe consequences, particularly in clinical applications.
What is better than Crispr?
• Traditional CRISPR/Cas9 editing uses guide RNAs. The guide RNAs target a
specific section of the DNA and the Cas9 enzyme initiates a break in the
double-stranded DNA structure at this location. This break is key for initiating
changes to the DNA. However, cellular repair of double-strand breaks can
lead to unintended DNA mutations, as well as the integration of exogenous
DNA to the human genome, which raises safety concerns for clinical
applications of CRISPR/Cas9 technology.
A safer alternative
• To minimize these unintended mutations, the Osaka University-led
research team proposed NICER.
• multiple NIcks (MNs) induced by Cas9 nickase and a
homologous Chromosome as an Endogenous Repair template.
• Because the NICER method does not involve DNA double-strand breaks
or the use of exogenous DNA, this technique appears to be a safe
alternative to conventional CRISPR/Cas9 methods. NICER may represent
a novel approach for the treatment of genetic diseases caused by
heterozygous mutations.
NICER